Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,627 | 1,317 | 422 | 917 | 1,798 |
| TOTAL | $2,024 | $1,481 | $944 | $1,641 | $2,235 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 |
| TOTAL | $1,500 | $1,500 | $1,500 | $1,500 | $1,500 |
| Total Assets | $3,524 | $2,981 | $2,444 | $3,141 | $3,735 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 81 | 119 | 132 | 206 | 194 |
| Accrued Expenses | 12,893 | 8,768 | 4,143 | 2,787 | 2,750 |
| Other current liabilities | 385 | 188 | N/A | 0 | N/A |
| TOTAL | $13,360 | $9,075 | $4,275 | $2,997 | $2,989 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $13,360 | $9,075 | $4,275 | $2,997 | $2,989 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,766 | 37,066 | 36,166 | N/A | 36,179 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -36,378 | -31,577 | -26,032 | -23,927 | -22,877 |
| Other shareholders' equity | 402 | 402 | 402 | 431 | 495 |
| TOTAL | $-9,836 | $-6,095 | $-1,831 | $144 | $746 |
| Total Liabilities And Equity | $3,524 | $2,981 | $2,444 | $3,141 | $3,735 |